期刊文献+

小剂量胺碘酮联合琥珀酸美托洛尔治疗肥厚型心肌病伴恶性室性心律失常患者疗效分析 被引量:5

原文传递
导出
摘要 目的分析小剂量胺碘酮联合美托洛尔对肥厚型心肌病合并恶性室性心律失常的效果。方法选取收治的78例肥厚型心肌病合并恶性室性心律失常患者随机分成甲组和乙组,甲组使用琥珀酸美托洛尔,乙组使用琥珀酸美托洛尔联合小剂量胺碘酮,比较两组的治疗效果。结果治疗前两组患者的心电图(QTmax、QTmin、QTd)指标、心功能(LVEF)指标比较差异无统计学意义(P>0.05),治疗后,乙组心电图、心功能指标改善程度、治疗有效率均优于甲组,猝死率明显低于甲组(P<0.05)。结论小剂量胺碘酮联合琥珀酸美托洛尔能有效改善肥厚型心肌病合并恶性室性心律失常患者出现的心律失常,改善患者心功能,提高预后效果,值得研究推广。
出处 《首都食品与医药》 2020年第10期79-79,共1页 Capital Food Medicine
  • 相关文献

二级参考文献23

  • 1Olsson SB. Executive steering committee of the SPORTIF III Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared withwarfarin in patients with non - valvular atrial fibrillation (SPORTIF III ) : randomised controlled trial[J]. Lancet, 2010, 362 (9397) : 1691 - 1698.
  • 2Bloomfield DM, Steinman RC, Namerow PB, et al. Microvoh T - wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Muhicenter Automatic Defibrillator Implantation Trial (MADIT) II co- nundrum[ J]. Circulation, 2004,110( 14 ) : 1885 - 1889.
  • 3The effect of low - dose warfarin on the risk of stroke in patients with nonrheumaticatrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillationlnvestigators[J]. N Engl J Med, 1990,323 ( 22 ) : 1505 - 1511.
  • 4Masayuki Yamaji,Takayoshi Tsutamoto,Chiho Kawahara,Keizo Nishiyama,Takashi Yamamoto,Masanori Fujii,Minoru Horie.Effect of eplerenone versus spironolactone on cortisol and hemoglobin A 1c levels in patients with chronic heart failure[J].American Heart Journal.2010(5)
  • 5RIKWILLEMS,KARIN R.SIPIDO,PATRICIAHOLEMANS,HUGOECTOR,FRANSWERF,HEINHEIDBüCHEL.Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation[J].Journal of Cardiovascular Electrophysiology.2003(12)
  • 6Saif S. Rathore,Alan K. Berger,Kevin P. Weinfurt,Kevin A. Schulman,William J. Oetgen,Bernard J. Gersh,Allen J. Solomon.Acute Myocardial Infarction Complicated by Atrial Fibrillation in the Elderly: Prevalence and Outcomes[J].Circulation: Journal of the American Heart Association.2000(9)
  • 7王峰,吴国霞,李玉兰.胺碘酮联合倍他乐克治疗室性心律失常的疗效观察[J].内蒙古医学杂志,2010,42(1):88-89. 被引量:25
  • 8何穗智,高学东,魏聪,欧顺云,邓卓燊,刘素芳,曾百乐,吴伟康,贾振华.参松养心胶囊治疗心律失常随机对照试验的系统评价[J].中国中医基础医学杂志,2010,16(2):158-160. 被引量:13
  • 9俞永美,裘文娟.胺碘酮治疗急性心肌梗死后再灌注心律失常的护理[J].护士进修杂志,2010,25(9):842-843. 被引量:9
  • 10柯友洋.倍他乐克联合可达龙、门冬氨酸钾镁治疗急性心肌梗塞并发恶性心律失常临床疗效观察[J].现代预防医学,2010,37(18):3578-3579. 被引量:17

共引文献33

同被引文献44

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部